Candel Therapeutics Inc (CADL)
6.03
+0.12
(+2.03%)
USD |
NASDAQ |
Apr 24, 16:00
6.03
0.00 (0.00%)
After-Hours: 20:00
Candel Therapeutics Price to Book Value: 13.89 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 23, 2024 | 13.61 |
April 22, 2024 | 12.76 |
April 19, 2024 | 11.90 |
April 18, 2024 | 12.57 |
April 17, 2024 | 12.53 |
April 16, 2024 | 13.56 |
April 15, 2024 | 13.40 |
April 12, 2024 | 15.34 |
April 11, 2024 | 16.76 |
April 10, 2024 | 11.74 |
April 09, 2024 | 11.72 |
April 08, 2024 | 14.81 |
April 05, 2024 | 15.29 |
April 04, 2024 | 14.74 |
April 03, 2024 | 3.868 |
April 02, 2024 | 3.892 |
April 01, 2024 | 4.030 |
March 28, 2024 | 3.638 |
March 27, 2024 | 3.546 |
March 26, 2024 | 3.431 |
March 25, 2024 | 3.500 |
March 22, 2024 | 3.454 |
March 21, 2024 | 3.339 |
March 20, 2024 | 3.424 |
March 19, 2024 | 3.424 |
Date | Value |
---|---|
March 18, 2024 | 3.196 |
March 15, 2024 | 3.424 |
March 14, 2024 | 3.561 |
March 13, 2024 | 3.584 |
March 12, 2024 | 3.675 |
March 11, 2024 | 3.835 |
March 08, 2024 | 3.584 |
March 07, 2024 | 3.492 |
March 06, 2024 | 3.606 |
March 05, 2024 | 3.720 |
March 04, 2024 | 3.766 |
March 01, 2024 | 3.880 |
February 29, 2024 | 4.246 |
February 28, 2024 | 4.086 |
February 27, 2024 | 3.972 |
February 26, 2024 | 4.063 |
February 23, 2024 | 3.994 |
February 22, 2024 | 3.955 |
February 21, 2024 | 4.017 |
February 20, 2024 | 3.926 |
February 16, 2024 | 3.926 |
February 15, 2024 | 3.972 |
February 14, 2024 | 3.858 |
February 13, 2024 | 4.109 |
February 12, 2024 | 3.173 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8203
Minimum
Oct 20 2022
16.76
Maximum
Apr 11 2024
2.202
Average
1.568
Median
Jul 25 2022
Price to Book Value Benchmarks
Allurion Technologies Inc | -- |
AngioDynamics Inc | 1.077 |
Eliem Therapeutics Inc | 0.9661 |
Macrogenics Inc | 6.431 |
GlycoMimetics Inc | 3.104 |
Price to Book Value Related Metrics
PS Ratio | 1407.10 |
Price | 6.03 |
Earnings Yield | -21.56% |
Market Cap | 176.97M |